Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Orditura

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Recenti Progressi in Medicina|May 1, 1994
Autologous bone marrow transplantation in Ki-1 lymphoma with poor prognosis. A case reportF De Vita, M Di Grazia, M Orditura, et al.
International Journal of Molecular Medicine|December 17, 1998
Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumorsM Orditura, F De Vita, A Roscigno, et al.
Recenti Progressi in Medicina|February 1, 1994
[Primary lymphoma of the parotid: a rare location]M Orditura, F De Vita, G Gugliotti, et al.
Tumori|February 24, 2001
The new European gold standard treatment for rectum cancerF De Vita, M Orditura, E Martinelli, et al.
Chest|February 12, 2000
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patientsF De Vita, M Orditura, G Galizia, et al.
Annali Italiani Di Chirurgia|July 1, 1998
[Leiomyosarcoma of the small intestines: case reports]L Capasso, N Carlomagno, F De Vita, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 15, 2001
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicatorF De Vita, C Romano, M Orditura, et al.
Oncology Reports|May 19, 2011
Prolonged corrected QT dispersionM Orditura, B Sarubbi, F Devita, et al.
Oncogene|May 29, 2007
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancerG Galizia, E Lieto, F De Vita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Chemoradiotherapy as adjuvant treatment of gastric cancerM Orditura, E Martinelli, G Galizia, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Recenti Progressi in Medicina|May 1, 1994
Autologous bone marrow transplantation in Ki-1 lymphoma with poor prognosis. A case reportF De Vita, M Di Grazia, M Orditura, et al.
International Journal of Molecular Medicine|December 17, 1998
Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumorsM Orditura, F De Vita, A Roscigno, et al.
Recenti Progressi in Medicina|February 1, 1994
[Primary lymphoma of the parotid: a rare location]M Orditura, F De Vita, G Gugliotti, et al.
Tumori|February 24, 2001
The new European gold standard treatment for rectum cancerF De Vita, M Orditura, E Martinelli, et al.
Chest|February 12, 2000
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patientsF De Vita, M Orditura, G Galizia, et al.
Annali Italiani Di Chirurgia|July 1, 1998
[Leiomyosarcoma of the small intestines: case reports]L Capasso, N Carlomagno, F De Vita, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 15, 2001
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicatorF De Vita, C Romano, M Orditura, et al.
Oncology Reports|May 19, 2011
Prolonged corrected QT dispersionM Orditura, B Sarubbi, F Devita, et al.
Oncogene|May 29, 2007
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancerG Galizia, E Lieto, F De Vita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Chemoradiotherapy as adjuvant treatment of gastric cancerM Orditura, E Martinelli, G Galizia, et al.
Pageof 6